FDA Inspection 1171990 — Florida Center For Allergy And Asthma Research
The FDA completed an inspection of Florida Center For Allergy And Asthma Research on Jun 10, 2022 in Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 10, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Miami, FL (United States)
Additional Details
Clinical BA/BE